Expertise in
14
conditions

Dr. Afsaneh A. Alavi

Dermatology
Mayo Clinic-Rochester
5716 Cleveland St Ste 200, 
Virginia Beach, VA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
14
conditions
Mayo Clinic-Rochester
5716 Cleveland St Ste 200, 
Virginia Beach, VA 

Overview

Afsaneh Alavi is a Dermatologist practicing medicine in Virginia Beach, Virginia.

Dr. Alavi is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Hidradenitis Suppurativa, Pyoderma Gangrenosum, Livedo Reticularis, and Calciphylaxis.

She is actively involved in clinical research, co-authoring 301 peer reviewed articles and participating in 6 clinical trials. Dr. Alavi is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in MN

Hospital Affiliations

Mayo Clinic Health System - Albert Lea And Austin
Mayo Clinic Hospital Rochester

Languages Spoken

English
Farsi

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avera Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Mayo Clinic-Rochester
5716 Cleveland St Ste 200, Virginia Beach, VA 23462
Other Locations
Mayo Clinic Blood Donor 41ST Street
4111 Highway 52 N, Rochester, MN 55901

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2, Dose-Escalation, Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
A Phase 2, Dose-Escalation, Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Enrollment Status: Completed
Publish Date: August 21, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: September 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
Enrollment Status: Terminated
Publish Date: August 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 5 Less Clinical Trials

301 Total Publications

Pyoderma Gangrenosum Phenotype Classification.
Pyoderma Gangrenosum Phenotype Classification.
Journal: JAMA dermatology
Published: August 05, 2026
Similar Doctors
Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required
Before you request

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
 (0.1 miles away)
507-284-2511
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Julia Lehman is a Dermatologist practicing medicine in Virginia Beach, Virginia. Dr. Lehman is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Lichen Planus, Pemphigoid Gestationis, Bullous Pemphigoid, and Pemphigus Foliaceus. Dr. Lehman is currently accepting new patients.

Expertise in
100
conditions
Expertise in
100
conditions
Referral required
Before you request

Integrated Dermatology Of Tidewater LLC

885 Kempsville Road, Suite 309, 
Norfolk, VA 
 (2.6 miles away)
757-461-1033
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jonathan Schreiber is a Dermatologist practicing medicine in Norfolk, Virginia. Dr. Schreiber is highly rated in 100 conditions, according to our data. His clinical expertise encompasses Fetal Cystic Hygroma, Cerebral Cavernous Malformation, Hemangioendothelioma, and Hemangioma. Dr. Schreiber is board certified in American Board Of Dermatology - Dermatology - 2032. Dr. Schreiber is currently accepting new patients.

Expertise in
133
conditions
Dr. Molly K. Smith
Dermatology
Expertise in
133
conditions
Dr. Molly K. Smith
Dermatology
Referral required
Before you request

Pariser Dermatology Specialists LTD.

6160 Kempsville Cir Ste 200A, 
Norfolk, VA 
 (3.4 miles away)
757-622-6315
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Molly Smith is a Dermatologist practicing medicine in Norfolk, Virginia. Dr. Smith is highly rated in 133 conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Basal Cell Skin Cancer, Seborrheic Keratosis, and Warts. Dr. Smith is currently accepting new patients.

Frequently Asked Questions about Dr. Afsaneh A. Alavi

How do I make an appointment with Dr. Afsaneh A. Alavi?

You can book an appointment with Dr. Afsaneh A. Alavi by calling their office at 507-284-2511. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Afsaneh A. Alavi a top-rated expert for Hidradenitis Suppurativa?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Afsaneh A. Alavi is classified as an Elite expert for Hidradenitis Suppurativa, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Afsaneh A. Alavi specialize in?

While Dr. Afsaneh A. Alavi is a Dermatology, they have specific expertise in Hidradenitis Suppurativa, Pyoderma Gangrenosum, and Livedo Reticularis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Afsaneh A. Alavi participate in research or clinical trials?

Yes. Dr. Afsaneh A. Alavi has published 301 articles and abstracts on conditions like Hidradenitis Suppurativa. You can view a list of Dr. Afsaneh A. Alavi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Afsaneh A. Alavi accept my insurance?

Dr. Afsaneh A. Alavi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 507-284-2511 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Alavi's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 67 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile